<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:06:31Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5687852" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5687852</identifier><datestamp>2017-11-18</datestamp><setSpec>sciadv</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Sci Adv</journal-id>
      <journal-id journal-id-type="iso-abbrev">Sci Adv</journal-id>
      <journal-id journal-id-type="publisher-id">SciAdv</journal-id>
      <journal-id journal-id-type="hwp">advances</journal-id>
      <journal-title-group>
        <journal-title>Science Advances</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2375-2548</issn>
      <publisher>
        <publisher-name>American Association for the Advancement of Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5687852</article-id>
      <article-id pub-id-type="pmcid">PMC5687852</article-id>
      <article-id pub-id-type="pmc-uid">5687852</article-id>
      <article-id pub-id-type="pmid">29152572</article-id>
      <article-id pub-id-type="publisher-id">aao1617</article-id>
      <article-id pub-id-type="doi">10.1126/sciadv.aao1617</article-id>
      <article-categories>
        <subj-group subj-group-type="article-type">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Research Articles</subject>
        </subj-group>
        <subj-group subj-group-type="legacy-article-type">
          <subject>SciAdv r-articles</subject>
        </subj-group>
        <subj-group subj-group-type="field">
          <subject>Health and Medicine</subject>
        </subj-group>
        <subj-group subj-group-type="overline">
          <subject>Health and Medicine</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A null mutation in <italic>SERPINE1</italic> protects against biological aging in humans</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>Sadiya S.</given-names>
          </name>
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0643-1859</contrib-id>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="author-notes" rid="afn1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shah</surname>
            <given-names>Sanjiv J.</given-names>
          </name>
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5655-8201</contrib-id>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="author-notes" rid="afn1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Klyachko</surname>
            <given-names>Ekaterina</given-names>
          </name>
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1089-180X</contrib-id>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baldridge</surname>
            <given-names>Abigail S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eren</surname>
            <given-names>Mesut</given-names>
          </name>
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4482-9550</contrib-id>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Place</surname>
            <given-names>Aaron T.</given-names>
          </name>
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0641-6635</contrib-id>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aviv</surname>
            <given-names>Abraham</given-names>
          </name>
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7441-0227</contrib-id>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Puterman</surname>
            <given-names>Eli</given-names>
          </name>
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5898-2348</contrib-id>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lloyd-Jones</surname>
            <given-names>Donald M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Heiman</surname>
            <given-names>Meadow</given-names>
          </name>
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5926-1382</contrib-id>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miyata</surname>
            <given-names>Toshio</given-names>
          </name>
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9153-5024</contrib-id>
          <xref ref-type="aff" rid="aff7">
            <sup>7</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>Sweta</given-names>
          </name>
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9340-305X</contrib-id>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shapiro</surname>
            <given-names>Amy D.</given-names>
          </name>
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2821-7159</contrib-id>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vaughan</surname>
            <given-names>Douglas E.</given-names>
          </name>
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8407-6613</contrib-id>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">â </xref>
        </contrib>
        <aff id="aff1"><label>1</label>Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.</aff>
        <aff id="aff2"><label>2</label>Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.</aff>
        <aff id="aff3"><label>3</label>Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.</aff>
        <aff id="aff4"><label>4</label>Center for Human Development and Aging, New Jersey Medical School, Newark, NJ 07103, USA.</aff>
        <aff id="aff5"><label>5</label>School of Kinesiology, University of British Columbia, Vancouver, British Columbia, Canada.</aff>
        <aff id="aff6"><label>6</label>Indiana Hemophilia and Thrombosis Center, Indianapolis, IN 46260, USA.</aff>
        <aff id="aff7"><label>7</label>Tohoku University Graduate School of Medicine, Miyagi, Japan.</aff>
      </contrib-group>
      <author-notes>
        <fn id="afn1" fn-type="equal">
          <label>*</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
        <corresp id="cor1"><label>â </label>Corresponding author. Email: <email xlink:href="d-vaughan@northwestern.edu">d-vaughan@northwestern.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>11</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>11</month>
        <year>2017</year>
      </pub-date>
      <volume>3</volume>
      <issue>11</issue>
      <elocation-id>eaao1617</elocation-id>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>6</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>10</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>The Authors</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" id="p-2">
          <license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution-NonCommercial license</ext-link>, which permits use, distribution, and reproduction in any medium, so long as the resultant use is <bold>not</bold> for commercial advantage and provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="teaser">
        <p>Humans with a rare gene mutation in <italic>SERPINE1</italic> live longer and show evidence of protection from aging-related morbidity.</p>
      </abstract>
      <abstract>
        <p>Plasminogen activator inhibitorâ1 (PAI-1) has been shown to be a key component of the senescence-related secretome and a direct mediator of cellular senescence. In murine models of accelerated aging, genetic deficiency and targeted inhibition of PAI-1 protect against aging-like pathology and prolong life span. However, the role of PAI-1 in human longevity remains unclear. We hypothesized that a rare loss-of-function mutation in <italic>SERPINE1</italic> (c.699_700dupTA), which encodes PAI-1, could play a role in longevity and metabolism in humans. We studied 177 members of the Berne Amish community, which included 43 carriers of the null <italic>SERPINE1</italic> mutation. Heterozygosity was associated with significantly longer leukocyte telomere length, lower fasting insulin levels, and lower prevalence of diabetes mellitus. In the extended Amish kindred, carriers of the null SERPINE1 allele had a longer life span. Our study indicates a causal effect of PAI-1 on human longevity, which may be mediated by alterations in metabolism. Our findings demonstrate the utility of studying loss-of-function mutations in populations with geographic and genetic isolation and shed light on a novel therapeutic target for aging.</p>
      </abstract>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000002</institution-id>
              <institution>National Institutes of Health</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award336021</award-id>
          <award-id>F32 HL129695</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000002</institution-id>
              <institution>National Institutes of Health</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award351840</award-id>
          <award-id>R01 HL107577</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000002</institution-id>
              <institution>National Institutes of Health</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award351841</award-id>
          <award-id>R01 HL127028</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000002</institution-id>
              <institution>National Institutes of Health</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award352250</award-id>
          <award-id>R01 HL051387</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000002</institution-id>
              <institution>National Institutes of Health</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award353576</award-id>
          <award-id>R01HD071180</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000002</institution-id>
              <institution>National Institutes of Health</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award353577</award-id>
          <award-id>R01HL116446</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000049</institution-id>
              <institution>National Institute on Aging</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award353156</award-id>
          <award-id>(CARDIA) AG0005</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000050</institution-id>
              <institution>National Heart, Lung, and Blood Institute</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award353150</award-id>
          <award-id>(CARDIA) University of Alabama, Birmingham, HHSN268201300025C</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000050</institution-id>
              <institution>National Heart, Lung, and Blood Institute</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award353151</award-id>
          <award-id>(CARDIA) University of Alabama, Birmingham, HHSN268201300026C</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000050</institution-id>
              <institution>National Heart, Lung, and Blood Institute</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award353152</award-id>
          <award-id>(CARDIA) Northwestern University, HHSN268201300027C</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000050</institution-id>
              <institution>National Heart, Lung, and Blood Institute</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award353153</award-id>
          <award-id>(CARDIA) University of Minnesota, HHSN268201300028C</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000050</institution-id>
              <institution>National Heart, Lung, and Blood Institute</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award353154</award-id>
          <award-id>(CARDIA) Kaiser Foundation Research Institute, HHSN268201300029C</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000050</institution-id>
              <institution>National Heart, Lung, and Blood Institute</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award353155</award-id>
          <award-id>(CARDIA) Johns Hopkins University School of Medicine, HHSN268200900041C</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000002</institution-id>
              <institution>National Institutes of Health</institution>
            </institution-wrap>
          </funding-source>
          <award-id>award353578</award-id>
          <award-id>R01HL134840</award-id>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Copyeditor</meta-name>
          <meta-value>Nielsen Marquez</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body><sec sec-type="introduction" disp-level="1"><title>INTRODUCTION</title><p>Age is the primary risk factor for most of the chronic diseases, including type 2 diabetes mellitus (DM), metabolic syndrome, and cardiovascular diseases (CVD) (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>). The prevalence of age-related diseases has increased concordantly with the growing proportion of elderly individuals in the population. Aging remains one of the most challenging biological processes to unravel, with coordinated and interrelated molecular and cellular changes (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>). Humans exhibit clear differential trajectories of age-related decline on a cellular level with telomere attrition across various somatic tissues and on a physiological level across multiple organ systems (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>). In addition to telomere length, LÃ³pez-OtÃ­n and colleagues (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>) proposed several molecular drivers of aging, including genomic instability, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. Despite knowledge of these potential molecular causes of aging, no targeted interventions currently exist to delay the aging process and to promote healthy longevity (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>, <xref rid="R6" ref-type="bibr"><italic>6</italic></xref>).</p><p>In the United States, cardiometabolic disease influences life span as a leading cause of death and disability in adult men and women (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>). Cardiometabolic disease is associated with a shorter leukocyte telomere length (LTL) (<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>, <xref rid="R9" ref-type="bibr"><italic>9</italic></xref>). Telomere shortening, which results from replication of somatic cells in vitro and in vivo, may cause replicative senescence. Senescent cells and tissues exhibit a distinctive pattern of protein expression, including increased plasminogen activator inhibitorâ1 (PAI-1) as a part of the senescence-associated secretory phenotype (SASP) (<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>, <xref rid="R11" ref-type="bibr"><italic>11</italic></xref>). PAI-1, which is encoded by the <italic>SERPINE1</italic> gene, is the primary inhibitor of endogenous plasminogen activators and is synthesized in the liver and fat tissue. In addition to its role in regulating fibrinolysis, PAI-1 also contributes directly to cellular senescence in vitro (<xref rid="R12" ref-type="bibr"><italic>12</italic></xref>). Genetic absence or pharmacologic inhibition of PAI-1 in murine models of accelerated aging provides protection from aging-like pathology, prevents telomere shortening, and prolongs life span (<xref rid="R13" ref-type="bibr"><italic>13</italic></xref>). Cross-sectional human studies have demonstrated an association of plasma levels of PAI-1 with insulin resistance (<xref rid="R14" ref-type="bibr"><italic>14</italic></xref>, <xref rid="R15" ref-type="bibr"><italic>15</italic></xref>). Mendelian randomization analyses from large genome-wide association studies (GWAS) provide an additional supportive evidence for a casual effect of PAI-1 on insulin resistance and coronary heart disease (<xref rid="R16" ref-type="bibr"><italic>16</italic></xref>).</p><p>The role of the SASP, in general, and specifically PAI-1 in longevity in humans is uncertain. We have previously reported the identification of a rare frameshift mutation (c.699_700dupTA) in the <italic>SERPINE1</italic> gene in the Old Order Amish (OOA), living in relative geographic and genetic isolation in the vicinity of Berne, Indiana; this mutation results in a lifelong reduction in PAI-1 levels (<xref rid="R17" ref-type="bibr"><italic>17</italic></xref>, <xref rid="R18" ref-type="bibr"><italic>18</italic></xref>). Therefore, we tested the association of carrier status for the null <italic>SERPINE1</italic> mutation with LTL as the prespecified primary end point in the only known cohort with a <italic>SERPINE1</italic> null mutation. The secondary end points of the study included fasting insulin level, prevalence of DM, and life span. The findings of this study were extended by assessing the novel aging scores derived in the OOA cohort in a U.S. populationâbased cohort study, the Coronary Artery Risk Development in Young Adults Study (CARDIA).</p></sec><sec sec-type="results" disp-level="1"><title>RESULTS</title><sec disp-level="2"><title>Baseline characteristics of the study participants</title><p>The clinical characteristics of the study participants by <italic>SERPINE1</italic> genotype status are shown in <xref ref-type="table" rid="T1">Table 1</xref> and table S1. A total of 177 participants was enrolled. Forty-three participants were identified as carriers of the null <italic>SERPINE1</italic> mutation, and seven participants were identified as homozygous for the null <italic>SERPINE1</italic> mutation with an overall minor (null) allele frequency of 16% in the study population. The observed <italic>SERPINE1</italic> genotype frequencies were in Hardy-Weinberg equilibrium. Heterozygous carriers of the null <italic>SERPINE1</italic> mutation had 50% lower mean circulating plasma PAI-1 levels (5.9 Â± 6.6 ng/ml versus 12.7 Â± 9.8 ng/ml; <italic>P</italic> &lt; 0.0001) compared with unaffected participants. Homozygous individuals for the null <italic>SERPINE1</italic> mutation had no evidence of detectable PAI-1 antigen in the plasma, consistent with the loss-of-function mutation. Unaffected Amish participants had lower body mass index, fasting glucose, and triglyceride levels than the CARDIA participants sampled from the U.S. urban communities (<xref ref-type="table" rid="T2">Table 2</xref>). Rates of clinically overt disease with hypertension and type 2 DM were similar in both unaffected Amish participants and the CARDIA participants.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Clinical characteristics of the Berne Amish kindred by <italic>SERPINE1</italic> genotype status.</title><p>Continuous values are listed as mean Â± SD unless otherwise specified. HDL, high-density lipoprotein; LDL, low-density lipoprotein.</p></caption><table frame="hsides" rules="groups"><col width="%" span="1"/><col width="%" span="1"/><col width="%" span="1"/><col width="%" span="1"/><thead><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"/><td valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold><italic>SERPINE1</italic><sup>+/+</sup></bold><break/><bold>(<italic>n</italic> = 127)</bold></td><td valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold><italic>SERPINE1</italic><sup>+/â</sup></bold><break/><bold>(<italic>n</italic> = 43)</bold></td><td valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold><italic>P</italic>*</bold></td></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="center" rowspan="1" colspan="1">46 Â± 20</td><td valign="top" align="center" rowspan="1" colspan="1">44 Â± 17</td><td valign="top" align="center" rowspan="1" colspan="1">0.97</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Female, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">70 (55)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (65)</td><td valign="top" align="center" rowspan="1" colspan="1">0.43</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hypertension, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">41 (33)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (33)</td><td valign="top" align="center" rowspan="1" colspan="1">0.85</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Systolic blood pressure (mmHg)</td><td valign="top" align="center" rowspan="1" colspan="1">130 Â±18</td><td valign="top" align="center" rowspan="1" colspan="1">128 Â± 20</td><td valign="top" align="center" rowspan="1" colspan="1">0.69</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Diastolic blood pressure (mmHg)</td><td valign="top" align="center" rowspan="1" colspan="1">77 Â± 10</td><td valign="top" align="center" rowspan="1" colspan="1">78 Â± 12</td><td valign="top" align="center" rowspan="1" colspan="1">0.60</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Obesity, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">38 (30)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (28)</td><td valign="top" align="center" rowspan="1" colspan="1">0.60</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td valign="top" align="center" rowspan="1" colspan="1">27.7 Â± 5.9</td><td valign="top" align="center" rowspan="1" colspan="1">26.9 Â± 6.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.29</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Diabetes, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Fasting insulin (uIU/ml)<sup>â </sup></td><td valign="top" align="center" rowspan="1" colspan="1">4.9 (3.3â6.7)</td><td valign="top" align="center" rowspan="1" colspan="1">4.0 (2.9â5.1)</td><td valign="top" align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total cholesterol (mg/dl)</td><td valign="top" align="center" rowspan="1" colspan="1">188 Â± 40</td><td valign="top" align="center" rowspan="1" colspan="1">188 Â± 55</td><td valign="top" align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">HDL cholesterol (mg/dl)</td><td valign="top" align="center" rowspan="1" colspan="1">60 Â± 15</td><td valign="top" align="center" rowspan="1" colspan="1">63 Â± 12</td><td valign="top" align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Triglyceride (mg/dl)<sup>â </sup></td><td valign="top" align="center" rowspan="1" colspan="1">81 (57â113)</td><td valign="top" align="center" rowspan="1" colspan="1">76 (51â110)</td><td valign="top" align="center" rowspan="1" colspan="1">0.54</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">LDL cholesterol (mg/dl)</td><td valign="top" align="center" rowspan="1" colspan="1">109 Â± 32</td><td valign="top" align="center" rowspan="1" colspan="1">107 Â± 44</td><td valign="top" align="center" rowspan="1" colspan="1">0.67</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Serum creatinine (mg/dl)</td><td valign="top" align="center" rowspan="1" colspan="1">0.80 Â± 0.16</td><td valign="top" align="center" rowspan="1" colspan="1">0.75 Â± 0.15</td><td valign="top" align="center" rowspan="1" colspan="1">0.13</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ever smoked, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">48 (38)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (28)</td><td valign="top" align="center" rowspan="1" colspan="1">0.11</td></tr></tbody></table><table-wrap-foot><p>*Polygenic model adjusted for carrier status and family structure in SOLAR.</p><p>â Non-normally distributed, reported as median (25th to 75th percentile).</p></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Comparison of clinical characteristics of the Berne Amish kindred <italic>SERPINE1</italic><sup><italic>+/+</italic></sup> and CARDIA.</title></caption><table frame="hsides" rules="groups"><col width="%" span="1"/><col width="%" span="1"/><col width="%" span="1"/><col width="%" span="1"/><thead><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"/><td valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold><italic>SERPINE1</italic><sup>+/+</sup></bold><break/><bold>(<italic>n</italic> = 127)</bold></td><td valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold><italic>CARDIA</italic></bold><break/><bold>(<italic>n</italic> = 2793)</bold></td><td valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold><italic>P</italic></bold></td></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="center" rowspan="1" colspan="1">46 Â± 20</td><td valign="top" align="center" rowspan="1" colspan="1">50 Â± 4</td><td valign="top" align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Female, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">70 (55)</td><td valign="top" align="center" rowspan="1" colspan="1">1605 (57)</td><td valign="top" align="center" rowspan="1" colspan="1">0.60</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hypertension, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">41 (33)</td><td valign="top" align="center" rowspan="1" colspan="1">1023 (37)</td><td valign="top" align="center" rowspan="1" colspan="1">0.42</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Systolic blood pressure (mmHg)</td><td valign="top" align="center" rowspan="1" colspan="1">130 Â± 18</td><td valign="top" align="center" rowspan="1" colspan="1">119 Â± 16</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Diastolic blood pressure (mmHg)</td><td valign="top" align="center" rowspan="1" colspan="1">77 Â± 10</td><td valign="top" align="center" rowspan="1" colspan="1">75 Â± 11</td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Obesity, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">38 (30)</td><td valign="top" align="center" rowspan="1" colspan="1">1181 (42)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td valign="top" align="center" rowspan="1" colspan="1">28 Â± 6</td><td valign="top" align="center" rowspan="1" colspan="1">30 Â± 7</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Diabetes, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">296 (11)</td><td valign="top" align="center" rowspan="1" colspan="1">0.17</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Fasting glucose (mg/dl)*</td><td valign="top" align="center" rowspan="1" colspan="1">88 (82â98)</td><td valign="top" align="center" rowspan="1" colspan="1">94 (87â102)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total cholesterol (mg/dl)</td><td valign="top" align="center" rowspan="1" colspan="1">188 Â± 40</td><td valign="top" align="center" rowspan="1" colspan="1">192 Â± 36</td><td valign="top" align="center" rowspan="1" colspan="1">0.23</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">HDL cholesterol (mg/dl)</td><td valign="top" align="center" rowspan="1" colspan="1">60 Â± 15</td><td valign="top" align="center" rowspan="1" colspan="1">58 Â± 18</td><td valign="top" align="center" rowspan="1" colspan="1">0.18</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Triglyceride (mg/dl)*</td><td valign="top" align="center" rowspan="1" colspan="1">81 (57â113)</td><td valign="top" align="center" rowspan="1" colspan="1">91 (68â132)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">LDL cholesterol (mg/dl)</td><td valign="top" align="center" rowspan="1" colspan="1">109 Â± 32</td><td valign="top" align="center" rowspan="1" colspan="1">112 Â± 32</td><td valign="top" align="center" rowspan="1" colspan="1">0.28</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Serum creatinine (mg/dl)</td><td valign="top" align="center" rowspan="1" colspan="1">0.80 Â± 0.16</td><td valign="top" align="center" rowspan="1" colspan="1">0.88 Â± 0.44</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ever smoked, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">48 (38)</td><td valign="top" align="center" rowspan="1" colspan="1">1007 (37)</td><td valign="top" align="center" rowspan="1" colspan="1">0.77</td></tr></tbody></table><table-wrap-foot><p>*Non-normally distributed, reported as median (25th to 75th percentile).</p></table-wrap-foot></table-wrap></sec><sec disp-level="2"><title>Association of null <italic>SERPINE1</italic> heterozygosity with telomere length and life span</title><p>Overall, the mean LTL was highly correlated with chronological age (<italic>R</italic> = â0.70, <italic>P</italic> &lt; 0.0001) and 9% shorter per decade of age (<italic>P</italic> &lt; 0.0001) in unaffected Amish participants. Carriers of the <italic>SERPINE1</italic> mutation had a 10% longer mean LTL, the prespecified primary end point, after adjustment for age, sex, and familial relatedness compared with noncarriers (<italic>P</italic> = 0.007) (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Interaction between age and carrier status of the <italic>SERPINE1</italic> null mutation in association with LTL was not significant. Secondary analyses, including participants who were homozygous for the <italic>SERPINE1</italic> null mutation (<italic>n</italic> = 7), demonstrated similar results (<italic>P</italic> = 0.020; table S2). The overall heritability (<italic>h</italic><sup>2</sup>) estimate of LTL was 0.55 (<italic>P</italic> &lt; 0.0001), suggesting that the additive effects of genetic variation, including the <italic>SERPINE1</italic> mutation, accounted for 55% of the total variation.</p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>Association of <italic>SERPINE1</italic> genotype status and leukocyte telomere length as a function of age in the Berne Amish kindred.</title><p>(<bold>A</bold> and <bold>B</bold>) LTL in <italic>SERPINE1</italic> null allele carriers and noncarriers in the Berne Amish kindred as quantified by (A) polymerase chain reaction (PCR) and (B) Southern Blot. Relative LTL is shown in (A), and mean terminal restriction fragment (TRF) length is shown in (B) as a function of age stratified by <italic>SERPINE1</italic> mutation status. <italic>P</italic> value represents difference in mean LTL and TRF by <italic>SERPINE1</italic> mutation status (carriers versus noncarriers) after adjustment for age, sex, and family structure in Sequential Oligogenic Linkage Analysis Routines (SOLAR) (<italic>P</italic> = 0.007 and <italic>P</italic> = 0.039, respectively). Every 1-year increase in age of study participant was associated with a 0.0087 lower relative LTL (<italic>P</italic> &lt; 0.0001) and a 30âbase pair lower mean TRF (<italic>P</italic> &lt; 0.0001).</p></caption><graphic xlink:href="aao1617-F1"/></fig><p>Vital status was available on 221 individuals identified as directly related to our study participants. Genotype status for <italic>SERPINE1</italic> was ascertained by direct genotyping or obligate ascertainment from ancestral data in deceased individuals with known dates of birth and death (<italic>n</italic> = 56). The median survival in <italic>SERPINE1</italic> null carriers compared with unaffected individuals was longer [85 (73 to 88) versus 75 (70 to 83); <italic>P</italic> = 0.037], as shown in <xref ref-type="fig" rid="F2">Fig. 2</xref>.</p><fig id="F2" fig-type="figure" orientation="portrait" position="float"><label>Fig. 2</label><caption><title>Age at death in the extended Berne Amish kindred by genotype status for <italic>SERPINE1</italic>.</title><p>On the basis of ancestral data obtained from the extended pedigree and extensive fieldwork, we identified 221 individuals with known dates of birth and death. Genotype status for <italic>SERPINE1</italic> was ascertained by direct genotyping or obligate ascertainment in 56 family members. The mean Â± SD age at death was delayed by 7 years in <italic>SERPINE1</italic> null carriers compared with unaffected individuals (82 Â± 10 versus 75 Â± 12; <italic>P</italic> = 0.037 by Wilcoxon rank sum test).</p></caption><graphic xlink:href="aao1617-F2"/></fig></sec><sec disp-level="2"><title>Association of null <italic>SERPINE1</italic> heterozygosity and metabolic traits</title><p>Carriers of the <italic>SERPINE1</italic> mutation had similar mean body mass index compared with noncarriers (<italic>P</italic> = 0.46). The prevalence of type 2 DM, one of the prespecified secondary end points, was significantly lower in carriers of the <italic>SERPINE1</italic> null mutation compared to noncarriers, as shown in <xref ref-type="table" rid="T1">Table 1</xref> (0% versus 7%; <italic>P</italic> = 0.001). Fasting insulin levels were 28% lower in <italic>SERPINE1</italic> heterozygotes (<italic>P</italic> = 0.035) after adjustment for age, sex, and familial relatedness in comparison to unaffected participants. Secondary analysis including Amish participants (<italic>n</italic> = 7) who were homozygous for the null <italic>SERPINE1</italic> mutation demonstrated similar results (<italic>P</italic> = 0.026). Sensitivity analysis performed with exclusion of Amish participants with diabetes did not alter the results. In addition, we observed a significant positive correlation between PAI-1 and fasting insulin levels in the Amish participants (<italic>R</italic> = 0.55, <italic>P</italic> &lt; 0.0001) and the CARDIA participants (<italic>R</italic> = 0.48, <italic>P</italic> &lt; 0.05).</p></sec><sec disp-level="2"><title>Association of null SERPINE1 heterozygosity and cardiovascular parameters</title><p>Tissue Doppler <italic>e</italic>â² velocity was slightly higher in carriers than controls but did not achieve significance (12.8 Â± 4.0 versus 12.3 Â± 4.1; <italic>P</italic> = not significant). Brachial pulse pressure [47 (42 to 53) versus 51 (44 to 57)] and carotid intima-media thickness (cIMT) [0.60 (0.51 to 0.72) versus 0.61 (0.52 to 0.79)] were lower in carriers than controls, but differences were not significant.</p><p>Several cardiovascular measures that correlated significantly with chronological age in unaffected individuals (|<italic>R</italic>| &gt; 0.60, <italic>P</italic> &lt; 0.0001; <xref ref-type="fig" rid="F3">Fig. 3</xref>) were identified. A composite score of cardiovascular aging that represents vascular and myocardial health (<italic>e</italic>â² velocity, brachial pulse pressure, and carotid IMT) was 0.6 units lower, on average, in carriers of the <italic>SERPINE1</italic> mutation than noncarriers, but this difference did not achieve statistical significance (<italic>P</italic> = 0.09). A second composite score representative of cardiometabolic aging that included cardiovascular parameters and fasting insulin was 1.03 units lower, on average, in carriers (<italic>P</italic> = 0.03). Composite score 3, which was representative of comprehensive biological aging, including score 2 parameters and relative LTL, was 0.53 units lower, on average, in carriers (<italic>P</italic> = 0.005).</p><fig id="F3" fig-type="figure" orientation="portrait" position="float"><label>Fig. 3</label><caption><title>Association of <italic>SERPINE1</italic> genotype status and cardiovascular measures of aging as a function of age in the Berne Amish kindred.</title><p>(<bold>A</bold> to <bold>C</bold>) Components of the aging composite scores, including brachial pulse pressure (A), <italic>e</italic>â² velocity (B), and carotid IMT (C) as a function age in Amish participants by genotype status for <italic>SERPINE1</italic> null allele. (<bold>D</bold> to <bold>F</bold>) Composite scores of cardiovascular, cardiometabolic, and comprehensive biological aging in <italic>SERPINE1</italic> null allele carriers and noncarriers in the Berne Amish kindred. Several cardiovascular measures that correlated strongly with chronological age with absolute correlation coefficients (|<italic>R</italic>|) greater than 0.60 (<italic>P</italic> &lt; 0.0001) were identified. Pulse pressure [PP = 34.7 + 0.39 (age in years)] and carotid IMT [0.32 + 0.01 (age in years)] increased with age. <italic>e</italic>â² velocity [<italic>e</italic>â² = 20.3 â 0.2 (age in years)] decreased with age, as expected. These measures of vascular structure and stiffness and myocardial health were then standardized to have mean = 0 and SD = 1 (<italic>z</italic> scores) and were integrated into composite score 1 (cardiovascular age composed of brachial pulse pressure, <italic>e</italic>â² velocity, and carotid IMT), composite score 2 (cardiometabolic age composed of score 1 plus fasting insulin), and composite score 3 (comprehensive biological age composed of score 2 and LTL). <italic>Z</italic> scores were coded so that higher values corresponded to older levels of the measures of biological aging; that is, The <italic>z</italic> scores for LTL and <italic>e</italic>â² velocity, which decline with age, were reverse-coded so that higher <italic>z</italic> scores corresponded to lower levels [**<italic>P</italic> value represents difference in components and composite scores of aging by <italic>SERPINE1</italic> mutation status (carriers versus noncarriers) after adjustment for age, sex, and family structure in SOLAR].</p></caption><graphic xlink:href="aao1617-F3"/></fig><p>These three composite scores of aging were assessed in the CARDIA cohort to determine their associations with cardiovascular outcomes. Each score was significantly associated with the 5-year outcomes of cardiovascular morbidity and mortality (tables S3 and S4). Similar results were obtained when restricting the analysis to white participants in CARDIA. In addition, plasma PAI-1 levels in the CARDIA participants correlated significantly with all three composite scores (<italic>R</italic> = 0.27, 0.42, and 0.39 for composite scores 1, 2, and 3, respectively; <italic>P</italic> &lt; 0.05).</p></sec><sec disp-level="2"><title>Founder identification in family structure pedigree</title><p>A simplified diagram of the extended Berne Amish pedigree highlighting individuals with heterozygosity and homozygosity for the null <italic>SERPINE1</italic> gene is shown in fig. S1. We identified either individual I-1 or I-2 as highly likely to have introduced a single copy of the mutated allele into the population six generations ago. This husband and wife couple is a common ancestor to all individuals newly and previously identified in the study as heterozygous or homozygous for the null <italic>SERPINE1</italic> allele. Although the genetically restricted nature of this cohort has resulted in a relatively high prevalence of the <italic>SERPINE1</italic> null allele, the mean kinship coefficient among carriers of the null <italic>SERPINE1</italic> allele was 7%. The oldest known homozygous individual for the <italic>SERPINE1</italic> mutation was born in 1981 as a result of the first marriage to occur between two heterozygotes. Although these individuals provide a unique opportunity to examine the biology of PAI-1 in humans, the rarity of this condition in the world and their young age limit comparisons at this time, but baseline characteristics are described (table S1).</p></sec></sec><sec sec-type="discussion" disp-level="1"><title>DISCUSSION</title><p>The central findings of our study are that heterozygosity for the null <italic>SERPINE1</italic> gene encoding PAI-1, which is associated with a lifelong reduction in PAI-1, is associated with longer LTL, a healthier metabolic profile with lower prevalence of diabetes, and a longer life span. The Berne Amish kindred provide an unprecedented opportunity to study the biological effects of a private loss-of-function mutation with a large effect on circulating PAI-1 on longevity in humans (<xref rid="R17" ref-type="bibr"><italic>17</italic></xref>, <xref rid="R18" ref-type="bibr"><italic>18</italic></xref>). We confirm previous reports that suggest that LTL is inversely correlated with chronological age and is substantially heritable (<xref rid="R19" ref-type="bibr"><italic>19</italic></xref>). In epidemiologic studies, LTL has been validated as a potent predictor of diabetes, CVD, and all-cause mortality (<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>, <xref rid="R9" ref-type="bibr"><italic>9</italic></xref>, <xref rid="R20" ref-type="bibr"><italic>20</italic></xref>â<xref rid="R22" ref-type="bibr"><italic>22</italic></xref>). In addition, inherited deficiencies in telomere maintenance in mice and humans manifest with an accelerated aging phenotype, supporting the critical role of telomere attrition in the pathophysiology of aging (<xref rid="R23" ref-type="bibr"><italic>23</italic></xref>, <xref rid="R24" ref-type="bibr"><italic>24</italic></xref>). These perspectives informed both our study design and the selection of LTL as the prespecified primary end point. Although age-adjusted LTL is significantly longer in the carriers of the null <italic>SERPINE1</italic> allele, the age-related phenomenon of LTL attrition across the cohort is the same. This supports previous data that absolute LTL may be largely determined at birth, and individuals with a longer LTL may shift the onset of insulin resistance and CVD to an older age, promoting longer life span (<xref rid="R25" ref-type="bibr"><italic>25</italic></xref>â<xref rid="R27" ref-type="bibr"><italic>27</italic></xref>).</p><p>The current study builds upon the available cellular and animal evidence supporting the role of PAI-1, the product of <italic>SERPINE1</italic>, as an important contributor to aging (<xref rid="R28" ref-type="bibr"><italic>28</italic></xref>). PAI-1 expression is increased in senescent cells and tissues and is a fundamental component of the SASP (<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>). There is a compelling evidence that senescent cells accumulate in the tissues and contribute to the aging process (<xref rid="R29" ref-type="bibr"><italic>29</italic></xref>, <xref rid="R30" ref-type="bibr"><italic>30</italic></xref>). In addition to contributing to the molecular fingerprint of senescence, PAI-1 is necessary and sufficient for the induction of replicative senescence in vitro and is a critical downstream target of the tumor suppressor p53 (<xref rid="R12" ref-type="bibr"><italic>12</italic></xref>, <xref rid="R31" ref-type="bibr"><italic>31</italic></xref>). The contribution of PAI-1 to cellular senescence is broadly relevant in the organism as a whole, and age-dependent increases in plasma PAI-1 levels have been identified in wild-type mice as they age, murine models of accelerated aging (<italic>Klotho</italic> and <italic>BubR1</italic><sup><italic>H/H</italic></sup>), and humans (<xref rid="R29" ref-type="bibr"><italic>29</italic></xref>, <xref rid="R32" ref-type="bibr"><italic>32</italic></xref>, <xref rid="R33" ref-type="bibr"><italic>33</italic></xref>). Partial PAI-1 deficiency in <italic>Klotho</italic>-deficient animals extended median survival nearly threefold with preserved telomere length and substantial protection against aging-like pathology in various organs (<xref rid="R13" ref-type="bibr"><italic>13</italic></xref>). Both genetic and pharmacological inhibition of PAI-1 protected against the development of hypertension and arteriosclerosis and was associated with longer telomere length in mice treated with long-term nitric oxide synthase inhibition (<xref rid="R34" ref-type="bibr"><italic>34</italic></xref>). These preclinical data are consistent with our findings of a longer LTL and a greater life span in carriers of the null <italic>SERPINE1</italic> allele in humans.</p><p>Metabolism plays a fundamental role in the biology of aging, and insulin and insulin-like growth factor 1 (IGF1) are widely endorsed as critical contributors to senescence and aging in several experimental models (for example, flies, worms, and mammals) (<xref rid="R35" ref-type="bibr"><italic>35</italic></xref>). Potential antiaging interventions have focused on caloric restriction and drugs with metabolic effects, including metformin and resveratrol, all of which mechanistically intersect in reducing PAI-1 expression (<xref rid="R36" ref-type="bibr"><italic>36</italic></xref>â<xref rid="R38" ref-type="bibr"><italic>38</italic></xref>). Conversely, PAI-1 production is enhanced by insulin, free fatty acids, and glucose (<xref rid="R39" ref-type="bibr"><italic>39</italic></xref>â<xref rid="R41" ref-type="bibr"><italic>41</italic></xref>). In addition, PAI-1 impairs the proteolytic degradation of IGF-binding proteinâ3 (IGFBP3) and IGF1, both of which are capable of initiating cellular senescence (<xref rid="R42" ref-type="bibr"><italic>42</italic></xref>, <xref rid="R43" ref-type="bibr"><italic>43</italic></xref>). In observational human studies, PAI-1 levels were higher in obesity and insulin resistance and independently predicted the future development of type 2 DM (<xref rid="R15" ref-type="bibr"><italic>15</italic></xref>, <xref rid="R44" ref-type="bibr"><italic>44</italic></xref>). In the only GWAS of circulating PAI-1 in 19,599 participants, a genotype-phenotype analysis identified a significant association between single-nucleotide polymorphisms (SNPs) that regulate PAI-1 and type 2 DM (<xref rid="R45" ref-type="bibr"><italic>45</italic></xref>). Further, Mendelian randomization analyses from large GWAS studies support a casual role for PAI-1 and hyperglycemia (<xref rid="R16" ref-type="bibr"><italic>16</italic></xref>). Here, we demonstrate that <italic>SERPINE1</italic> null carriers have lower fasting insulin levels and lower prevalence of type 2 DM, and in a diverse U.S. populationâbased study (CARDIA), we demonstrate that circulating PAI-1 levels are strongly correlated with fasting insulin levels.</p><p>Our findings from the only known PAI-1âdeficient kindred provide the first example of a private gene mutation on age-dependent molecular and metabolic changes in humans. Whole-genome sequencing and GWAS for healthy aging and life span have had limited success in identifying associated genetic loci, supporting the value of rare genetic variants (such as the one described here) in understanding biological mechanisms that regulate aging and life span (<xref rid="R46" ref-type="bibr"><italic>46</italic></xref>â<xref rid="R48" ref-type="bibr"><italic>48</italic></xref>). The genetic mechanism of PAI-1 deficiency in the Berne Amish kindred is explained by the presence of a dinucleotide insertion (TA) within the coding sequence of the PAI-1 gene (exon 4), resulting in a frameshift mutation and formation of a premature stop codon and the synthesis of a truncated, nonfunctional PAI-1 protein. This frameshift mutation has not been identified in the general population based on the sequence data publicly available for review from 60,706 unrelated individuals in the Exome Aggregation Consortium (ExAC). Ten distinct loss-of-function mutations, including three frameshift mutations, are reported in the ExAC database in <italic>SERPINE1</italic> and have exceedingly rare mutated allele prevalence ranging from 0.000008239 to 0.0005850 (<xref rid="R49" ref-type="bibr"><italic>49</italic></xref>). Further, in GWAS, SNPs account for no more than 3.7% of the total variation in plasma PAI-1 levels beyond that of age and sex (<xref rid="R45" ref-type="bibr"><italic>45</italic></xref>). Therefore, discovery and validation of <italic>SERPINE1</italic> SNPs in GWAS of longevity may be difficult, given the limited contribution of these variants in the general population to circulating PAI-1 levels, and highlight the strength of our study with a large effect size on circulating PAI-1 levels as a result of a loss-of-function mutation.</p><p>Additional longitudinal studies in this cohort will help inform potential links between the null <italic>SERPINE1</italic> mutation, metabolism, and life span. Although there is a possibility that the <italic>SERPINE1</italic> mutation segregates with other mutations that may contribute to the phenotype observed, the qualitative and quantitative effects we observed with <italic>SERPINE1</italic> heterozygosity in humans are fully concordant with the predicted effects observed in preclinical experimental models (<xref rid="R13" ref-type="bibr"><italic>13</italic></xref>, <xref rid="R34" ref-type="bibr"><italic>34</italic></xref>). We acknowledge that the generalizability of the findings identified here may be limited, given that this cohort carries a rare private mutation, is functionally isolated from the âmodern worldâ in several ways, and appears to be relatively healthier when compared to a general population sample as represented by CARDIA. Average plasma PAI-1 levels even in unaffected Amish participants without the null <italic>SERPINE1</italic> allele were 50% lower than participants enrolled in U.S. populationâbased cohorts such as CARDIA and the Framingham Heart Study (<xref rid="R50" ref-type="bibr"><italic>50</italic></xref>).</p><p>Use of small-molecule selective inhibitors of human PAI-1 or other components of the SASP may be of interest in preventing or treating age-related morbidities. Orally active PAI-1 inhibitors have already completed extensive preclinical evaluation and are currently in early-phase clinical testing in humans in Japan (<xref rid="R34" ref-type="bibr"><italic>34</italic></xref>, <xref rid="R51" ref-type="bibr"><italic>51</italic></xref>). The absence of bleeding complications in heterozygotes for the <italic>SERPINE1</italic> mutation in over 20 years of clinical observation suggests that therapeutic agents that selectively reduce but incompletely inhibit PAI-1 activity may be safe from a hemostatic perspective (<xref rid="R17" ref-type="bibr"><italic>17</italic></xref>).</p><p>Our study has several limitations. First, our results are based on an observational study and include limited assessments of LTL, metabolic parameters and disease, and measures of cardiovascular structure and function. Given the current lack of consensus regarding the quantitative assessment of biological age, we developed novel composite scores of aging that integrate age-dependent physiological measures of cardiovascular health including vascular structure and stiffness, subclinical atherosclerosis, myocardial relaxation, and LTL (<xref rid="R52" ref-type="bibr"><italic>52</italic></xref>, <xref rid="R53" ref-type="bibr"><italic>53</italic></xref>). Although we demonstrate that our composite scores are significantly associated with the 5-year cardiovascular outcomes in CARDIA, events are limited, and these quantitative assessments should be replicated in additional population-based cohorts with longer follow-up times. Second, although the aging phenotype of homozygous individuals is certainly of interest, these individuals are extremely rare in the kindred and relatively young (all less than 34 years old), limiting any meaningful comparisons at the present time. Therefore, we focused on the potential impact of <italic>SERPINE1</italic> heterozygosity and LTL in this study. Third, all of the heterozygous participants share a common ancestor in generation I from the late 1800s, and this lends a possibility that other unidentified genetic or epigenetic factors contribute to the present findings. To mitigate this risk, we adjusted our analyses for relatedness in SOLAR (<xref rid="R54" ref-type="bibr"><italic>54</italic></xref>).</p><p>In conclusion, our data indicate that PAI-1 is associated with a number of parameters that may reflect biological aging, including LTL, metabolism, and life span. Overall, our findings are the first to identify the physiological association of a null mutation in PAI-1 with LTL and life span in humans and suggest that PAI-1, a component of the senescence-related secretome, may influence the aging process. Future studies will provide the opportunity to investigate the contribution of PAI-1 to individual telomere attrition over time, the development of incident diabetes and other age-related diseases, and perhaps ultimately differences in health and life span in humans.</p></sec><sec sec-type="materials|methods" disp-level="1"><title>MATERIALS AND METHODS</title><sec disp-level="2"><title>Amish study participants</title><p>This cross-sectional observational study was conducted in the OOAâa founder population who originally settled in Berne, Indiana, which is characterized by a homogeneous diet and lifestyleâand included participants aged 18 years and older. The Institutional Review Board at the Indiana Hemophilia and Thrombosis Center and the Northwestern University approved the study protocol. A total of 450 individuals was invited to participate in the study, and 177 individuals were enrolled in the study. All study participants provided written informed consent and were genotyped for the c.699_700dupTA frameshift mutation in <italic>SERPINE1</italic>. For the primary analyses, participants homozygous for the null <italic>SERPINE1</italic> allele were excluded because of small numbers (<italic>n</italic> = 7) and their relatively young age (18 to 34 years). The primary end point of telomere length and the secondary end points of fasting insulin, diabetes status, and life span were prospectively selected.</p></sec><sec disp-level="2"><title>Molecular markers and laboratory testing</title><p>Genotyping for <italic>SERPINE1</italic> null mutation status was performed at the University of Michigan with a preidentified primer for the presence of the c.699_700dupTA frameshift mutation in the PAI-1 (<italic>SERPINE1</italic>) gene. Genomic DNA isolated from peripheral blood leukocytes (DNeasy Blood and Tissue kit, Qiagen) was used to measure relative LTL by quantitative PCR and TRF length by Southern blot by blinded technicians using previously described methods (<xref rid="R55" ref-type="bibr"><italic>55</italic></xref>â<xref rid="R57" ref-type="bibr"><italic>57</italic></xref>). Quantitative PCR samples were run in triplicate, and Southern blot samples were run in duplicate. The inter-assay coefficient of variation (CV) was 9.6% for relative LTL and 2.5% for mean TRF.</p><p>Plasma samples preserved in citrate were assayed for human PAI-1 total antigen with the Molecular Innovations PAI-1 ELISA (Molecular Innovations) using BioTek Synergy HT Gen5 software (BioTek). All samples were run in duplicate, and the mean of two measurements was used. The intra-assay CV was 6.15%, and the inter-assay CV was 5.98%. Metabolites (glucose and insulin) and cholesterol (total cholesterol, HDL cholesterol, LDL cholesterol, and triglyceride) were measured in morning fasting blood samples according to a standardized protocol in the main laboratory at the Northwestern Memorial Hospital.</p></sec><sec disp-level="2"><title>Cardiovascular assessment</title><p>All study participants underwent a comprehensive two-dimensional echocardiographic examination with Doppler and tissue Doppler imaging using a commercially available ultrasound system with harmonic imaging (Vivid 7 or Vivid i, GE Healthcare) and a 3.5-MHz transducer (GE Healthcare) by blinded sonographers. Cardiac structure and function were quantified as recommended by the American Society of Echocardiography (ASE) (<xref rid="R58" ref-type="bibr"><italic>58</italic></xref>). Deidentified images were copied in RAW format and analyzed offline using GE EchoPAC software version 7.0.0 (GE Healthcare). All measurements were made by a single experienced research sonographer and verified by an experienced investigator with expertise in echocardiography (both blinded to clinical data and genotype status) according to the guidelines of the ASE.</p><p>Carotid imaging was performed by an experienced sonographer blinded to genotype status using a commercially available ultrasound machine (Vivid 7 or Vivid i, GE Healthcare) and an 8-MHz transducer (GE Healthcare). Deidentified images were copied in RAW format for offline analysis and analyzed using GE EchoPAC software version 7.0.0 (GE Healthcare). All measurements were performed by a single experienced research sonographer and verified by an experienced investigator (both blinded to clinical data and genotype status). IMT measurements were performed using GEâs semiautomated edge detection method according to the ASE recommendations (<xref rid="R59" ref-type="bibr"><italic>59</italic></xref>).</p></sec><sec disp-level="2"><title>Genealogical information and life span</title><p>Detailed genealogic data spanning three generations were obtained from each participant. The pedigree was supplemented by an extensive fieldwork to fill in available birth and death dates and was used to adjust for family relatedness by calculation of kinship matrix for each of our enrolled participants in the SOLAR polygenic models. We additionally used ancestral data from the extended pedigree for life-span analysis. We restricted our life-span analysis to individuals known to have died at the age of â¥45 years to minimize the potential bias from premature cause of death, including infection, accidental trauma, and childbirth, as previously described in similar analyses (<xref rid="R60" ref-type="bibr"><italic>60</italic></xref>).</p></sec><sec disp-level="2"><title>Validation of composite aging scores</title><p>We sought to validate the biological aging composite scores in a generalized U.S. population using the CARDIA study. The CARDIA study is a multicenter, community-based longitudinal cohort study designed to investigate the risk factors for the development of CVD. In 1985â1986, 5115 black and white men and women aged 18 to 30 years were recruited from four urban sites across the United States (Birmingham, AL; Chicago, IL; Minneapolis, MN; and Oakland, CA). Recruitment was balanced within each center by sex, age, race, and education. The CARDIA participants have been followed for more than 30 years with collection of detailed demographic and clinical data. All participants provided written informed consent at each examination, and institutional review boards from each field center and the coordinating center approved the study annually. Detailed descriptions of the study design and conduct had been previously published (<xref rid="R61" ref-type="bibr"><italic>61</italic></xref>). For this analysis, all participants who attended the year-25 examination and had available data for components of composite scores 1 and 2 were included (<italic>N</italic> = 2793). A subset of participants who also had data for composite score 3 (<italic>n</italic> = 892) were also examined separately.</p></sec><sec disp-level="2"><title>Statistical analysis</title><p>We compared baseline demographics between heterozygous and unaffected participants with adjustment for family structure. We used polygenic models adjusted for age, sex, and family structure to determine the association of heterozygosity in <italic>SERPINE1</italic> with LTL as the primary end point, as measured by quantitative PCR and Southern blot. We estimated heritability (<italic>h</italic><sup>2</sup>) defined as the proportion of total variation explained by additive genetic effects for LTL. We also investigated the association of <italic>SERPINE1</italic> status with parameters of metabolism, including fasting insulin and the prevalence of type 2 DM and life span. Composite scores of aging were created by the summation of standardized <italic>z</italic> scores among aging-related characteristics that had the highest values for Pearson correlation with chronological age (|<italic>R</italic>| &gt; 0.5). Composite score 1 included log-transformed brachial pulse pressure, tissue Doppler <italic>e</italic>â² velocity (a marker of left ventricular relaxation), and log-transformed average carotid IMT. Composite score 2 included components in score 1 and fasting insulin, and composite score 3 included components of score 2 and LTL. The three composite aging scores were validated in a generalized U.S. population using the CARDIA study.</p><p>Supplemental descriptive analysis was performed including the homozygous participants (<italic>n</italic> = 7) with limited power given their small sample size and young age. Polygenic analyses were conducted using SOLAR (version 8.1.1; Southwest Foundation for Biomedical Research). All other analyses were conducted using SAS software version 9.4 (SAS Institute). Two-sided <italic>P</italic> values &lt;0.05 were considered to be statistically significant.</p></sec></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title>http://advances.sciencemag.org/cgi/content/full/3/11/eaao1617/DC1</title>
</caption>
<media mimetype="text" mime-subtype="html" xlink:href="supp_3_11_eaao1617__index.html"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="aao1617_SM.pdf"/>
</supplementary-material>
</sec>
</body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank our Amish liaisons and the Indiana Hemophilia and Thrombosis Centerâs Research clinic staff, as well as the Feinberg Cardiovascular Research Institute volunteers. In addition, we extend our deepest gratitude to the Berne Amish community for their time, participation, and support, without which these studies would not have been possible. A pedigree is also included in the Supplementary Materials and is abbreviated to provide anonymity. We thank the participants of the CARDIA study for their long-term commitment and important contributions to the study. <bold>Funding:</bold> This work was supported by grants from the NIH (R01 HL051387 to D.E.V.; F32 HL129695 to S.S.K.; R01 HL127028 and HL107577 to S.J.S.; and R01HD071180, R01HL116446, and R01HL134840 to A.A.). The CARDIA is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham (HHSN268201300025C and HHSN268201300026C), Northwestern University (HHSN268201300027C), University of Minnesota (HHSN268201300028C), Kaiser Foundation Research Institute (HHSN268201300029C), and Johns Hopkins University School of Medicine (HHSN268200900041C). CARDIA is also supported, in part, by the Intramural Research Program of the National Institute on Aging (NIA) and an intra-agency agreement between NIA and NHLBI (AG0005). This manuscript has been reviewed by CARDIA for scientific content. <bold>Author contributions:</bold> D.E.V., S.S.K., and S.J.S. provided substantial contribution to the conception and design of the study, data acquisition and analysis, and drafting and critical revision of the manuscript. A.S.B. contributed to data analysis and critical manuscript revisions. E.K., M.E., A.T.P., D.M.L.-J., E.P., A.A., T.M., and M.H. contributed to data acquisition and critical revision of the manuscript. S.G. and A.D.S. contributed substantially to the conception and design of the study, data acquisition, and critical revision of the manuscript. All coauthors approved the final version of the manuscript to be published and agreed to be accountable for the accuracy and integrity of all aspects of the work. D.E.V. claims responsibility for all figures in the manuscript and the Supplementary Materials. <bold>Competing interests:</bold> The authors declare that they have no competing interests. <bold>Data and materials availability:</bold> All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Additional data related to this paper may be requested from the authors.</p>
    </ack>
    <app-group>
      <app>
        <title>SUPPLEMENTARY MATERIALS</title>
        <supplementary-material content-type="local-data">
          <p>Supplementary material for this article is available at <ext-link ext-link-type="uri" xlink:href="http://advances.sciencemag.org/cgi/content/full/3/11/eaao1617/DC1">http://advances.sciencemag.org/cgi/content/full/3/11/eaao1617/DC1</ext-link></p>
          <p>Supplementary Materials and Methods</p>
          <p>table S1. Clinical characteristics of homozygous participants for the null <italic>SERPINE1</italic> mutation.</p>
          <p>table S2. Association of null <italic>SERPINE1</italic> mutant allele status with PAI-1, telomere length, and fasting insulin: secondary analyses.</p>
          <p>table S3. Association of cardiometabolic aging composite scores with 5-year CVD morbidity and mortality in the CARDIA cohort (<italic>n</italic> = 2793).</p>
          <p>table S4. Association of biological aging composite scores including telomere length with 5-year CVD morbidity and mortality in the CARDIA cohort (<italic>n</italic> = 872).</p>
          <p>fig. S1. Abbreviated pedigree of the Berne Amish kindred.</p>
        </supplementary-material>
      </app>
    </app-group>
    <ref-list>
      <title>REFERENCES AND NOTES</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaeberlein</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rabinovitch</surname><given-names>P. S.</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>G. M.</given-names></name></person-group>, 
<article-title>Healthy aging: The ultimate preventative medicine</article-title>. <source>Science</source>
<volume>350</volume>, 
<fpage>1191</fpage>â<lpage>1193</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26785476</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fontana</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Partridge</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Longo</surname><given-names>V. D.</given-names></name></person-group>, 
<article-title>Extending healthy life spanâFrom yeast to humans</article-title>. <source>Science</source>
<volume>328</volume>, 
<fpage>321</fpage>â<lpage>326</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20395504</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daniali</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Benetos</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Susser</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Kark</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Labat</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Kimura</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Desai</surname><given-names>K. K.</given-names></name>, <name name-style="western"><surname>Granick</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Aviv</surname><given-names>A.</given-names></name></person-group>, 
<article-title>Telomeres shorten at equivalent rates in somatic tissues of adults</article-title>. <source>Nat. Commun.</source>
<volume>4</volume>, 
<fpage>1597</fpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23511462</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LÃ³pez-OtÃ­n</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Blasco</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Partridge</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Serrano</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kroemer</surname><given-names>G.</given-names></name></person-group>, 
<article-title>The hallmarks of aging</article-title>. <source>Cell</source>
<volume>153</volume>, 
<fpage>1194</fpage>â<lpage>1217</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23746838</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Longo</surname><given-names>V. D.</given-names></name>, <name name-style="western"><surname>Antebi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bartke</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Barzilai</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Brown-Borg</surname><given-names>H. M.</given-names></name>, <name name-style="western"><surname>Caruso</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Curiel</surname><given-names>T. J.</given-names></name>, <name name-style="western"><surname>de Cabo</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Franceschi</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Gems</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Ingram</surname><given-names>D. K.</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>T. E.</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>B. K.</given-names></name>, <name name-style="western"><surname>Kenyon</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kopchick</surname><given-names>J. J.</given-names></name>, <name name-style="western"><surname>Lepperdinger</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Madeo</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Mirisola</surname><given-names>M. G.</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>J. R.</given-names></name>, <name name-style="western"><surname>Passarino</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Rudolph</surname><given-names>K. L.</given-names></name>, <name name-style="western"><surname>Sedivy</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Shadel</surname><given-names>G. S.</given-names></name>, <name name-style="western"><surname>Sinclair</surname><given-names>D. A.</given-names></name>, <name name-style="western"><surname>Spindler</surname><given-names>S. R.</given-names></name>, <name name-style="western"><surname>Suh</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Vijg</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Vinciguerra</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fontana</surname><given-names>L.</given-names></name></person-group>, 
<article-title>Interventions to slow aging in humans: Are we ready?</article-title>
<source>Aging Cell</source>
<volume>14</volume>, 
<fpage>497</fpage>â<lpage>510</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25902704</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LÃ³pez-OtÃ­n</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Galluzzi</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Freije</surname><given-names>J. M. P.</given-names></name>, <name name-style="western"><surname>Madeo</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Kroemer</surname><given-names>G.</given-names></name></person-group>, 
<article-title>Metabolic control of longevity</article-title>. <source>Cell</source>
<volume>166</volume>, 
<fpage>802</fpage>â<lpage>821</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27518560</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kochanek</surname><given-names>K. D.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>S. L.</given-names></name>, <name name-style="western"><surname>Minino</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Kung</surname><given-names>H.-C.</given-names></name></person-group>, 
<article-title>Deaths: Preliminary data for 2009</article-title>. <source>Natl. Vital Stat. Rep.</source>
<volume>59</volume>, 
<fpage>1</fpage>â<lpage>51</lpage> (<year>2011</year>).</mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DâMello</surname><given-names>M. J. J.</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Briel</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Anand</surname><given-names>S. S.</given-names></name>, <name name-style="western"><surname>Gerstein</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>ParÃ©</surname><given-names>G.</given-names></name></person-group>, 
<article-title>Association between shortened leukocyte telomere length and cardiometabolic outcomes: Systematic review and meta-analysis</article-title>. <source>Circ. Cardiovasc. Genet.</source>
<volume>8</volume>, 
<fpage>82</fpage>â<lpage>90</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25406241</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haycock</surname><given-names>P. C.</given-names></name>, <name name-style="western"><surname>Heydon</surname><given-names>E. E.</given-names></name>, <name name-style="western"><surname>Kaptoge</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Butterworth</surname><given-names>A. S.</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Willeit</surname><given-names>P.</given-names></name></person-group>, 
<article-title>Leucocyte telomere length and risk of cardiovascular disease: Systematic review and meta-analysis</article-title>. <source>BMJ</source>
<volume>349</volume>, 
<fpage>g4227</fpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25006006</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tchkonia</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>van Deursen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Campisi</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kirkland</surname><given-names>J. L.</given-names></name></person-group>, 
<article-title>Cellular senescence and the senescent secretory phenotype: therapeutic opportunities</article-title>. <source>J. Clin. Invest.</source>
<volume>123</volume>, 
<fpage>966</fpage>â<lpage>972</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23454759</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ãzcan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Alessio</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Acar</surname><given-names>M. B.</given-names></name>, <name name-style="western"><surname>Mert</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Omerli</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Peluso</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Galderisi</surname><given-names>U.</given-names></name></person-group>, 
<article-title>Unbiased analysis of senescence associated secretory phenotype (SASP) to identify common components following different genotoxic stresses</article-title>. <source>Aging</source>
<volume>8</volume>, 
<fpage>1316</fpage>â<lpage>1329</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27288264</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kortlever</surname><given-names>R. M.</given-names></name>, <name name-style="western"><surname>Higgins</surname><given-names>P. J.</given-names></name>, <name name-style="western"><surname>Bernards</surname><given-names>R.</given-names></name></person-group>, 
<article-title>Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence</article-title>. <source>Nat. Cell Biol.</source>
<volume>8</volume>, 
<fpage>877</fpage>â<lpage>884</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16862142</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eren</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Boe</surname><given-names>A. E.</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>S. B.</given-names></name>, <name name-style="western"><surname>Place</surname><given-names>A. T.</given-names></name>, <name name-style="western"><surname>Nagpal</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Morales-Nebreda</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Urich</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Quaggin</surname><given-names>S. E.</given-names></name>, <name name-style="western"><surname>Budinger</surname><given-names>G. R. S.</given-names></name>, <name name-style="western"><surname>Mutlu</surname><given-names>G. M.</given-names></name>, <name name-style="western"><surname>Miyata</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Vaughan</surname><given-names>D. E.</given-names></name></person-group>, 
<article-title>PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>111</volume>, 
<fpage>7090</fpage>â<lpage>7095</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24778222</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alessi</surname><given-names>M. C.</given-names></name>, <name name-style="western"><surname>Juhan-Vague</surname><given-names>I.</given-names></name></person-group>, 
<article-title>PAI-1 and the metabolic syndrome: Links, causes, and consequences</article-title>. <source>Arterioscler. Thromb. Vasc. Biol.</source>
<volume>26</volume>, 
<fpage>2200</fpage>â<lpage>2207</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16931789</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Festa</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>DâAgostino</surname><given-names>R.</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Tracy</surname><given-names>R. P.</given-names></name>, <name name-style="western"><surname>Haffner</surname><given-names>S. M.</given-names></name></person-group>; <collab>Insulin Resistance Atherosclerosis Study</collab>, 
<article-title>Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: The insulin resistance atherosclerosis study</article-title>. <source>Diabetes</source>
<volume>51</volume>, 
<fpage>1131</fpage>â<lpage>1137</lpage> (<year>2002</year>).<pub-id pub-id-type="pmid">11916936</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Burgess</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Eicher</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>OâDonnell</surname><given-names>C. J.</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>A. D.</given-names></name></person-group>, 
<article-title>Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease</article-title>. <source>J. Am. Heart Assoc.</source>
<volume>6</volume>, 
<fpage>e004918</fpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28550093</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fay</surname><given-names>W. P.</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>A. C.</given-names></name>, <name name-style="western"><surname>Condrey</surname><given-names>L. R.</given-names></name>, <name name-style="western"><surname>Shapiro</surname><given-names>A. D.</given-names></name></person-group>, 
<article-title>Human plasminogen activator inhibitor-1 (PAI-1) deficiency: Characterization of a large kindred with a null mutation in the PAI-1 gene</article-title>. <source>Blood</source>
<volume>90</volume>, 
<fpage>204</fpage>â<lpage>208</lpage> (<year>1997</year>).<pub-id pub-id-type="pmid">9207454</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fay</surname><given-names>W. P.</given-names></name>, <name name-style="western"><surname>Shapiro</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Shih</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Schleef</surname><given-names>R. R.</given-names></name>, <name name-style="western"><surname>Ginsburg</surname><given-names>D.</given-names></name></person-group>, 
<article-title>Brief report: Complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation</article-title>. <source>N. Engl. J. Med.</source>
<volume>327</volume>, 
<fpage>1729</fpage>â<lpage>1733</lpage> (<year>1992</year>).<pub-id pub-id-type="pmid">1435917</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Njajou</surname><given-names>O. T.</given-names></name>, <name name-style="western"><surname>Cawthon</surname><given-names>R. M.</given-names></name>, <name name-style="western"><surname>Damcott</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>S.-H.</given-names></name>, <name name-style="western"><surname>Ott</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Garant</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Blackburn</surname><given-names>E. H.</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>B. D.</given-names></name>, <name name-style="western"><surname>Shuldiner</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Hsueh</surname><given-names>W.-C.</given-names></name></person-group>, 
<article-title>Telomere length is paternally inherited and is associated with parental lifespan</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>104</volume>, 
<fpage>12135</fpage>â<lpage>12139</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17623782</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cawthon</surname><given-names>R. M.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>K. R.</given-names></name>, <name name-style="western"><surname>OâBrien</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Sivatchenko</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kerber</surname><given-names>R. A.</given-names></name></person-group>, 
<article-title>Association between telomere length in blood and mortality in people aged 60 years or older</article-title>. <source>Lancet</source>
<volume>361</volume>, 
<fpage>393</fpage>â<lpage>395</lpage> (<year>2003</year>).<pub-id pub-id-type="pmid">12573379</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Codd</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>C. P.</given-names></name>, <name name-style="western"><surname>Albrecht</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Mangino</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Deelen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Buxton</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Jan Hottenga</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Fischer</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Esko</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Surakka</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Broer</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Nyholt</surname><given-names>D. R.</given-names></name>, <name name-style="western"><surname>Mateo Leach</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Salo</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>HÃ¤gg</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Matthews</surname><given-names>M. K.</given-names></name>, <name name-style="western"><surname>Palmen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Norata</surname><given-names>G. D.</given-names></name>, <name name-style="western"><surname>OâReilly</surname><given-names>P. F.</given-names></name>, <name name-style="western"><surname>Saleheen</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Amin</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Balmforth</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Beekman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>de Boer</surname><given-names>R. A.</given-names></name>, <name name-style="western"><surname>BÃ¶hringer</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Braund</surname><given-names>P. S.</given-names></name>, <name name-style="western"><surname>Burton</surname><given-names>P. R.</given-names></name>, <name name-style="western"><surname>de Craen</surname><given-names>A. J. M.</given-names></name>, <name name-style="western"><surname>Denniff</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Douroudis</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Dubinina</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Eriksson</surname><given-names>J. G.</given-names></name>, <name name-style="western"><surname>Garlaschelli</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Hartikainen</surname><given-names>A.-L.</given-names></name>, <name name-style="western"><surname>Henders</surname><given-names>A. K.</given-names></name>, <name name-style="western"><surname>Houwing-Duistermaat</surname><given-names>J. J.</given-names></name>, <name name-style="western"><surname>Kananen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Karssen</surname><given-names>L. C.</given-names></name>, <name name-style="western"><surname>Kettunen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Klopp</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Lagou</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>van Leeuwen</surname><given-names>E. M.</given-names></name>, <name name-style="western"><surname>Madden</surname><given-names>P. A.</given-names></name>, <name name-style="western"><surname>MÃ¤gi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Magnusson</surname><given-names>P. K. E.</given-names></name>, <name name-style="western"><surname>MÃ¤nnistÃ¶</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>McCarthy</surname><given-names>M. I.</given-names></name>, <name name-style="western"><surname>Medland</surname><given-names>S. E.</given-names></name>, <name name-style="western"><surname>Mihailov</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Montgomery</surname><given-names>G. W.</given-names></name>, <name name-style="western"><surname>Oostra</surname><given-names>B. A.</given-names></name>, <name name-style="western"><surname>Palotie</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Peters</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Pollard</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Pouta</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Prokopenko</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Ripatti</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Salomaa</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Suchiman</surname><given-names>H. E. D.</given-names></name>, <name name-style="western"><surname>Valdes</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Verweij</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>ViÃ±uela</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Wichmann</surname><given-names>H.-E.</given-names></name>, <name name-style="western"><surname>Widen</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Willemsen</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>van Veldhuisen</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Catapano</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Tobin</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>A. S.</given-names></name>, <name name-style="western"><surname>Blakemore</surname><given-names>A. I. F.</given-names></name>, <name name-style="western"><surname>van Gilst</surname><given-names>W. H.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name></person-group>; <collab>CARDIoGRAM consortium</collab>; <person-group person-group-type="author"><name name-style="western"><surname>Erdmann</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Reilly</surname><given-names>M. P.</given-names></name>, <name name-style="western"><surname>Kathiresan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Schunkert</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Talmud</surname><given-names>P. J.</given-names></name>, <name name-style="western"><surname>Pedersen</surname><given-names>N. L.</given-names></name>, <name name-style="western"><surname>Perola</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ouwehand</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Kaprio</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>N. G.</given-names></name>, <name name-style="western"><surname>van Duijn</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Hovatta</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Gieger</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Metspalu</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Boomsma</surname><given-names>D. I.</given-names></name>, <name name-style="western"><surname>Jarvelin</surname><given-names>M.-R.</given-names></name>, <name name-style="western"><surname>Slagboom</surname><given-names>P. E.</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>J. R.</given-names></name>, <name name-style="western"><surname>Spector</surname><given-names>T. D.</given-names></name>, <name name-style="western"><surname>van der Harst</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Samani</surname><given-names>N. J.</given-names></name></person-group>, 
<article-title>Identification of seven loci affecting mean telomere length and their association with disease</article-title>. <source>Nat. Genet.</source>
<volume>45</volume>, 
<fpage>422</fpage>â<lpage>427</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23535734</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Miao</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D. W.</given-names></name></person-group>, 
<article-title>Association between telomere length and type 2 diabetes mellitus: A meta-analysis</article-title>. <source>PLOS ONE</source>
<volume>8</volume>, 
<fpage>e79993</fpage> (<year>2013</year>).<pub-id pub-id-type="pmid">24278229</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armanios</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Blackburn</surname><given-names>E. H.</given-names></name></person-group>, 
<article-title>The telomere syndromes</article-title>. <source>Nat. Rev. Genet.</source>
<volume>13</volume>, 
<fpage>693</fpage>â<lpage>704</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22965356</pub-id></mixed-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blasco</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>H.-W.</given-names></name>, <name name-style="western"><surname>Hande</surname><given-names>M. P.</given-names></name>, <name name-style="western"><surname>Samper</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Lansdorp</surname><given-names>P. M.</given-names></name>, <name name-style="western"><surname>DePinho</surname><given-names>R. A.</given-names></name>, <name name-style="western"><surname>Greider</surname><given-names>C. W.</given-names></name></person-group>, 
<article-title>Telomere shortening and tumor formation by mouse cells lacking telomerase RNA</article-title>. <source>Cell</source>
<volume>91</volume>, 
<fpage>25</fpage>â<lpage>34</lpage> (<year>1997</year>).<pub-id pub-id-type="pmid">9335332</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benetos</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kark</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Susser</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Kimura</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sinnreich</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Steenstrup</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Christensen</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Herbig</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>von Bornemann Hjelmborg</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Srinivasan</surname><given-names>S. R.</given-names></name>, <name name-style="western"><surname>Berenson</surname><given-names>G. S.</given-names></name>, <name name-style="western"><surname>Labat</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Aviv</surname><given-names>A.</given-names></name></person-group>, 
<article-title>Tracking and fixed ranking of leukocyte telomere length across the adult life course</article-title>. <source>Aging Cell</source>
<volume>12</volume>, 
<fpage>615</fpage>â<lpage>621</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23601089</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Factor-Litvak</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Susser</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Kezios</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>McKeague</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Kark</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Hoffman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kimura</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wapner</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Aviv</surname><given-names>A.</given-names></name></person-group>, 
<article-title>Leukocyte telomere length in newborns: Implications for the role of telomeres in human disease</article-title>. <source>Pediatrics</source>
<volume>137</volume>, 
<fpage>e20153927</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">26969272</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunt</surname><given-names>S. C.</given-names></name>, <name name-style="western"><surname>Kark</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Aviv</surname><given-names>A.</given-names></name></person-group>, 
<article-title>Association between shortened leukocyte telomere length and cardio-metabolic outcomes</article-title>. <source>Circ. Cardiovasc. Genet.</source>
<volume>8</volume>, 
<fpage>4</fpage>â<lpage>7</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25691684</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cesari</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pahor</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Incalzi</surname><given-names>R. A.</given-names></name></person-group>, 
<article-title>Plasminogen activator inhibitor-1 (PAI-1): A key factor linking fibrinolysis and age-related subclinical and clinical conditions</article-title>. <source>Cardiovasc. Ther.</source>
<volume>28</volume>, 
<fpage>e72</fpage>â<lpage>e91</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20626406</pub-id></mixed-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baker</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Childs</surname><given-names>B. G.</given-names></name>, <name name-style="western"><surname>Durik</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wijers</surname><given-names>M. E.</given-names></name>, <name name-style="western"><surname>Sieben</surname><given-names>C. J.</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Saltness</surname><given-names>R. A.</given-names></name>, <name name-style="western"><surname>Jeganathan</surname><given-names>K. B.</given-names></name>, <name name-style="western"><surname>Verzosa</surname><given-names>G. C.</given-names></name>, <name name-style="western"><surname>Pezeshki</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Khazaie</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>van Deursen</surname><given-names>J. M.</given-names></name></person-group>, 
<article-title>Naturally occurring p16<sup>Ink4a</sup>-positive cells shorten healthy lifespan</article-title>. <source>Nature</source>
<volume>530</volume>, 
<fpage>184</fpage>â<lpage>189</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">26840489</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Demaria</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>OâLeary</surname><given-names>M. N.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Shao</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Alimirah</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Koenig</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Le</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Mitin</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Deal</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Alston</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Academia</surname><given-names>E. C.</given-names></name>, <name name-style="western"><surname>Kilmarx</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Valdovinos</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>de Bruin</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>B. K.</given-names></name>, <name name-style="western"><surname>Melov</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sharpless</surname><given-names>N. E.</given-names></name>, <name name-style="western"><surname>Muss</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Campisi</surname><given-names>J.</given-names></name></person-group>, 
<article-title>Cellular senescence promotes adverse effects of chemotherapy and cancer relapse</article-title>. <source>Cancer Discov.</source>
<volume>7</volume>, 
<fpage>165</fpage>â<lpage>176</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">27979832</pub-id></mixed-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Serrano</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>A. W.</given-names></name>, <name name-style="western"><surname>McCurrach</surname><given-names>M. E.</given-names></name>, <name name-style="western"><surname>Beach</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Lowe</surname><given-names>S. W.</given-names></name></person-group>, 
<article-title>Oncogenic <italic>ras</italic> provokes premature cell senescence associated with accumulation of p53 and p16<sup>INK4a</sup></article-title>. <source>Cell</source>
<volume>88</volume>, 
<fpage>593</fpage>â<lpage>602</lpage> (<year>1997</year>).<pub-id pub-id-type="pmid">9054499</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeshita</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kondo</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Matsushita</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hirai</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kojima</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Nishimura</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Nabeshima</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Loskutoff</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Murohara</surname><given-names>T.</given-names></name></person-group>, 
<article-title>Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murine model of aging, â<italic>Klotho</italic>â mouse</article-title>. <source>Semin. Thromb. Hemost.</source>
<volume>28</volume>, 
<fpage>545</fpage>â<lpage>554</lpage> (<year>2002</year>).<pub-id pub-id-type="pmid">12536348</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aillaud</surname><given-names>M. F.</given-names></name>, <name name-style="western"><surname>Pignol</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Alessi</surname><given-names>M. C.</given-names></name>, <name name-style="western"><surname>Harle</surname><given-names>J. R.</given-names></name>, <name name-style="western"><surname>Escande</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mongin</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Juhan-Vague</surname><given-names>I.</given-names></name></person-group>, 
<article-title>Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age</article-title>. <source>Thromb. Haemost.</source>
<volume>55</volume>, 
<fpage>330</fpage>â<lpage>332</lpage> (<year>1986</year>).<pub-id pub-id-type="pmid">3092390</pub-id></mixed-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boe</surname><given-names>A. E.</given-names></name>, <name name-style="western"><surname>Eren</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>S. B.</given-names></name>, <name name-style="western"><surname>Kamide</surname><given-names>C. E.</given-names></name>, <name name-style="western"><surname>Ichimura</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Terry</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>McAnally</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>L. H.</given-names></name>, <name name-style="western"><surname>Miyata</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Vaughan</surname><given-names>D. E.</given-names></name></person-group>, 
<article-title>Plasminogen activator inhibitor-1 antagonist TM5441 attenuates N<sup>Ï</sup>-nitro-<sc>l</sc>-arginine methyl esterâinduced hypertension and vascular senescence</article-title>. <source>Circulation</source>
<volume>128</volume>, 
<fpage>2318</fpage>â<lpage>2324</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">24092817</pub-id></mixed-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tatar</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bartke</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Antebi</surname><given-names>A.</given-names></name></person-group>, 
<article-title>The endocrine regulation of aging by insulin-like signals</article-title>. <source>Science</source>
<volume>299</volume>, 
<fpage>1346</fpage>â<lpage>1351</lpage> (<year>2003</year>).<pub-id pub-id-type="pmid">12610294</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ãlholm</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Paulsen</surname><given-names>S. K.</given-names></name>, <name name-style="western"><surname>Cullberg</surname><given-names>K. B.</given-names></name>, <name name-style="western"><surname>Richelsen</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Pedersen</surname><given-names>S. B.</given-names></name></person-group>, 
<article-title>Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants</article-title>. <source>Int. J. Obes.</source>
<volume>34</volume>, 
<fpage>1546</fpage>â<lpage>1553</lpage> (<year>2010</year>).</mixed-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagi</surname><given-names>D. K.</given-names></name>, <name name-style="western"><surname>Yudkin</surname><given-names>J. S.</given-names></name></person-group>, 
<article-title>Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects: A study of two ethnic groups</article-title>. <source>Diabetes Care</source>
<volume>16</volume>, 
<fpage>621</fpage>â<lpage>629</lpage> (<year>1993</year>).<pub-id pub-id-type="pmid">8462390</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colman</surname><given-names>R. J.</given-names></name>, <name name-style="western"><surname>Beasley</surname><given-names>T. M.</given-names></name>, <name name-style="western"><surname>Kemnitz</surname><given-names>J. W.</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>S. C.</given-names></name>, <name name-style="western"><surname>Weindruch</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>R. M.</given-names></name></person-group>, 
<article-title>Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys</article-title>. <source>Nat. Commun.</source>
<volume>5</volume>, 
<fpage>3557</fpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24691430</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nilsson</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Banfi</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Diczfalusy</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Tremoli</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Hamsten</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Eriksson</surname><given-names>P.</given-names></name></person-group>, 
<article-title>Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells</article-title>. <source>Arterioscler. Thromb. Vasc. Biol.</source>
<volume>18</volume>, 
<fpage>1679</fpage>â<lpage>1685</lpage> (<year>1998</year>).<pub-id pub-id-type="pmid">9812904</pub-id></mixed-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alessi</surname><given-names>M. C.</given-names></name>, <name name-style="western"><surname>Juhan-Vague</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Kooistra</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Declerck</surname><given-names>P. J.</given-names></name>, <name name-style="western"><surname>Collen</surname><given-names>D.</given-names></name></person-group>, 
<article-title>Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2</article-title>. <source>Thromb. Haemost.</source>
<volume>60</volume>, 
<fpage>491</fpage>â<lpage>494</lpage> (<year>1988</year>).<pub-id pub-id-type="pmid">3149048</pub-id></mixed-citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y.-Q.</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Walia</surname><given-names>R. R.</given-names></name>, <name name-style="western"><surname>Hao</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Covington</surname><given-names>J. W.</given-names></name>, <name name-style="western"><surname>Vaughan</surname><given-names>D. E.</given-names></name></person-group>, 
<article-title>Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells</article-title>. <source>J. Biol. Chem.</source>
<volume>273</volume>, 
<fpage>8225</fpage>â<lpage>8231</lpage> (<year>1998</year>).<pub-id pub-id-type="pmid">9525928</pub-id></mixed-citation>
      </ref>
      <ref id="R42">
        <label>42</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deelen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Uh</surname><given-names>H.-W.</given-names></name>, <name name-style="western"><surname>Monajemi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>van Heemst</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Thijssen</surname><given-names>P. E.</given-names></name>, <name name-style="western"><surname>BÃ¶hringer</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>van den Akker</surname><given-names>E. B.</given-names></name>, <name name-style="western"><surname>de Craen</surname><given-names>A. J. M.</given-names></name>, <name name-style="western"><surname>Rivadeneira</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Uitterlinden</surname><given-names>A. G.</given-names></name>, <name name-style="western"><surname>Westendorp</surname><given-names>R. G. J.</given-names></name>, <name name-style="western"><surname>Goeman</surname><given-names>J. J.</given-names></name>, <name name-style="western"><surname>Slagboom</surname><given-names>P. E.</given-names></name>, <name name-style="western"><surname>Houwing-Duistermaat</surname><given-names>J. J.</given-names></name>, <name name-style="western"><surname>Beekman</surname><given-names>M.</given-names></name></person-group>, 
<article-title>Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin/IGF-1 signaling and telomere maintenance pathways</article-title>. <source>Age</source>
<volume>35</volume>, 
<fpage>235</fpage>â<lpage>249</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">22113349</pub-id></mixed-citation>
      </ref>
      <ref id="R43">
        <label>43</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elzi</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hakala</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Weintraub</surname><given-names>S. T.</given-names></name>, <name name-style="western"><surname>Shiio</surname><given-names>Y.</given-names></name></person-group>, 
<article-title>Plasminogen activator inhibitor 1âInsulin-like growth factor binding protein 3 cascade regulates stress-induced senescence</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>109</volume>, 
<fpage>12052</fpage>â<lpage>12057</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22778398</pub-id></mixed-citation>
      </ref>
      <ref id="R44">
        <label>44</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosito</surname><given-names>G. A.</given-names></name>, <name name-style="western"><surname>DâAgostino</surname><given-names>R. B.</given-names></name>, <name name-style="western"><surname>Massaro</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lipinska</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Mittleman</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Sutherland</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>P. W. F.</given-names></name>, <name name-style="western"><surname>Levy</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Muller</surname><given-names>J. E.</given-names></name>, <name name-style="western"><surname>Tofler</surname><given-names>G. H.</given-names></name></person-group>, 
<article-title>Association between obesity and a prothrombotic state: The Framingham Offspring Study</article-title>. <source>Thromb. Haemost.</source>
<volume>91</volume>, 
<fpage>683</fpage>â<lpage>689</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15045128</pub-id></mixed-citation>
      </ref>
      <ref id="R45">
        <label>45</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Sabater-Lleal</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Asselbergs</surname><given-names>F. W.</given-names></name>, <name name-style="western"><surname>Tregouet</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>S.-Y.</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Baumert</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Oudot-Mellakh</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Folkersen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>N. L.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>S. M.</given-names></name>, <name name-style="western"><surname>Ikram</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Kleber</surname><given-names>M. E.</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>D. M.</given-names></name>, <name name-style="western"><surname>Truong</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Mychaleckyj</surname><given-names>J. C.</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Sennblad</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>F. M. K.</given-names></name>, <name name-style="western"><surname>Dehghan</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Silbernagel</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Schrijvers</surname><given-names>E. M. C.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Karakas</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tofler</surname><given-names>G. H.</given-names></name>, <name name-style="western"><surname>Silveira</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Navis</surname><given-names>G. J.</given-names></name>, <name name-style="western"><surname>Lohman</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>M.-H.</given-names></name>, <name name-style="western"><surname>Peters</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Goel</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hopewell</surname><given-names>J. C.</given-names></name>, <name name-style="western"><surname>Chambers</surname><given-names>J. C.</given-names></name>, <name name-style="western"><surname>Saleheen</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Lundmark</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Psaty</surname><given-names>B. M.</given-names></name>, <name name-style="western"><surname>Strawbridge</surname><given-names>R. J.</given-names></name>, <name name-style="western"><surname>Boehm</surname><given-names>B. O.</given-names></name>, <name name-style="western"><surname>Carter</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Meisinger</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Peden</surname><given-names>J. F.</given-names></name>, <name name-style="western"><surname>Bis</surname><given-names>J. C.</given-names></name>, <name name-style="western"><surname>McKnight</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Ãhrvik</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Franzosi</surname><given-names>M. G.</given-names></name>, <name name-style="western"><surname>Seedorf</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Franco-Cereceda</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>SyvÃ¤nen</surname><given-names>A.-C.</given-names></name>, <name name-style="western"><surname>Goodall</surname><given-names>A. H.</given-names></name>, <name name-style="western"><surname>Yanek</surname><given-names>L. R.</given-names></name>, <name name-style="western"><surname>Cushman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>MÃ¼ller-Nurasyid</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Folsom</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Basu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Matijevic</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>van Gilst</surname><given-names>W. H.</given-names></name>, <name name-style="western"><surname>Kooner</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Hofman</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Danesh</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Clarke</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Meigs</surname><given-names>J. B.</given-names></name></person-group>; <collab>DIAGRAM Consortium</collab>; <person-group person-group-type="author"><name name-style="western"><surname>Kathiresan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Reilly</surname><given-names>M. P.</given-names></name></person-group>; <collab>CARDIoGRAM Consortium</collab>; <person-group person-group-type="author"><name name-style="western"><surname>Klopp</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>T. B.</given-names></name>, <name name-style="western"><surname>Winkelmann</surname><given-names>B. R.</given-names></name>, <name name-style="western"><surname>Grant</surname><given-names>P. J.</given-names></name>, <name name-style="western"><surname>Hillege</surname><given-names>H. L.</given-names></name>, <name name-style="western"><surname>Watkins</surname><given-names>H.</given-names></name></person-group>; <collab>C4D Consortium</collab>; <person-group person-group-type="author"><name name-style="western"><surname>Spector</surname><given-names>T. D.</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>L. C.</given-names></name>, <name name-style="western"><surname>Tracy</surname><given-names>R. P.</given-names></name>, <name name-style="western"><surname>MÃ¤rz</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Uitterlinden</surname><given-names>A. G.</given-names></name>, <name name-style="western"><surname>Eriksson</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Cambien</surname><given-names>F.</given-names></name></person-group>; <collab>CARDIOGENICS Consortium</collab>; <person-group person-group-type="author"><name name-style="western"><surname>Morange</surname><given-names>P.-E.</given-names></name>, <name name-style="western"><surname>Koenig</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Soranzo</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>van der Harst</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>OâDonnell</surname><given-names>C. J.</given-names></name>, <name name-style="western"><surname>Hamsten</surname><given-names>A.</given-names></name></person-group>, 
<article-title>Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation</article-title>. <source>Blood</source>
<volume>120</volume>, 
<fpage>4873</fpage>â<lpage>4881</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22990020</pub-id></mixed-citation>
      </ref>
      <ref id="R46">
        <label>46</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erikson</surname><given-names>G. A.</given-names></name>, <name name-style="western"><surname>Bodian</surname><given-names>D. L.</given-names></name>, <name name-style="western"><surname>Rueda</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Molparia</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>E. R.</given-names></name>, <name name-style="western"><surname>Scott-Van Zeeland</surname><given-names>A. A.</given-names></name>, <name name-style="western"><surname>Topol</surname><given-names>S. E.</given-names></name>, <name name-style="western"><surname>Wineinger</surname><given-names>N. E.</given-names></name>, <name name-style="western"><surname>Niederhuber</surname><given-names>J. E.</given-names></name>, <name name-style="western"><surname>Topol</surname><given-names>E. J.</given-names></name>, <name name-style="western"><surname>Torkamani</surname><given-names>A.</given-names></name></person-group>, 
<article-title>Whole-genome sequencing of a healthy aging cohort</article-title>. <source>Cell</source>
<volume>165</volume>, 
<fpage>1002</fpage>â<lpage>1011</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27114037</pub-id></mixed-citation>
      </ref>
      <ref id="R47">
        <label>47</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christensen</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>T. E.</given-names></name>, <name name-style="western"><surname>Vaupel</surname><given-names>J. W.</given-names></name></person-group>, 
<article-title>The quest for genetic determinants of human longevity: Challenges and insights</article-title>. <source>Nat. Rev. Genet.</source>
<volume>7</volume>, 
<fpage>436</fpage>â<lpage>448</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16708071</pub-id></mixed-citation>
      </ref>
      <ref id="R48">
        <label>48</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deelen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Beekman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Uh</surname><given-names>H.-W.</given-names></name>, <name name-style="western"><surname>Helmer</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Kuningas</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Christiansen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kremer</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>van der Breggen</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Suchiman</surname><given-names>H. E. D.</given-names></name>, <name name-style="western"><surname>Lakenberg</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>van den Akker</surname><given-names>E. B.</given-names></name>, <name name-style="western"><surname>Passtoors</surname><given-names>W. M.</given-names></name>, <name name-style="western"><surname>Tiemeier</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>van Heemst</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>de Craen</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Rivadeneira</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>de Geus</surname><given-names>E. J.</given-names></name>, <name name-style="western"><surname>Perola</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>van der Ouderaa</surname><given-names>F. J.</given-names></name>, <name name-style="western"><surname>Gunn</surname><given-names>D. A.</given-names></name>, <name name-style="western"><surname>Boomsma</surname><given-names>D. I.</given-names></name>, <name name-style="western"><surname>Uitterlinden</surname><given-names>A. G.</given-names></name>, <name name-style="western"><surname>Christensen</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>van Duijn</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Heijmans</surname><given-names>B. T.</given-names></name>, <name name-style="western"><surname>Houwing-Duistermaat</surname><given-names>J. J.</given-names></name>, <name name-style="western"><surname>Westendorp</surname><given-names>R. G. J.</given-names></name>, <name name-style="western"><surname>Slagboom</surname><given-names>P. E.</given-names></name></person-group>, 
<article-title>Genome-wide association study identifies a single major locus contributing to survival into old age; the <italic>APOE</italic> locus revisited</article-title>. <source>Aging Cell</source>
<volume>10</volume>, 
<fpage>686</fpage>â<lpage>698</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21418511</pub-id></mixed-citation>
      </ref>
      <ref id="R49">
        <label>49</label>
        <mixed-citation publication-type="web">Exome Aggregation Consortium, ExAC Browser (Beta) (ExAC, 2016); <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org">http://exac.broadinstitute.org</ext-link>.</mixed-citation>
      </ref>
      <ref id="R50">
        <label>50</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lieb</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Larson</surname><given-names>M. G.</given-names></name>, <name name-style="western"><surname>Benjamin</surname><given-names>E. J.</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Tofler</surname><given-names>G. H.</given-names></name>, <name name-style="western"><surname>Selhub</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Jacques</surname><given-names>P. F.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>T. J.</given-names></name>, <name name-style="western"><surname>Vita</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Levy</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Vasan</surname><given-names>R. S.</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>G. F.</given-names></name></person-group>, 
<article-title>Multimarker approach to evaluate correlates of vascular stiffness: The Framingham Heart Study</article-title>. <source>Circulation</source>
<volume>119</volume>, 
<fpage>37</fpage>â<lpage>43</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19103986</pub-id></mixed-citation>
      </ref>
      <ref id="R51">
        <label>51</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Izuhara</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yamaoka</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Kodama</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Dan</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Takizawa</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hirayama</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Meguro</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>van Ypersele de Strihou</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Miyata</surname><given-names>T.</given-names></name></person-group>, 
<article-title>A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates</article-title>. <source>J. Cereb. Blood Flow Metab.</source>
<volume>30</volume>, 
<fpage>904</fpage>â<lpage>912</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20087372</pub-id></mixed-citation>
      </ref>
      <ref id="R52">
        <label>52</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belsky</surname><given-names>D. W.</given-names></name>, <name name-style="western"><surname>Caspi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Houts</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>H. J.</given-names></name>, <name name-style="western"><surname>Corcoran</surname><given-names>D. L.</given-names></name>, <name name-style="western"><surname>Danese</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Harrington</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Israel</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Levine</surname><given-names>M. E.</given-names></name>, <name name-style="western"><surname>Schaefer</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Sugden</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Yashin</surname><given-names>A. I.</given-names></name>, <name name-style="western"><surname>Poulton</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Moffitt</surname><given-names>T. E.</given-names></name></person-group>, 
<article-title>Quantification of biological aging in young adults</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>112</volume>, 
<fpage>E4104</fpage>â<lpage>E4110</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26150497</pub-id></mixed-citation>
      </ref>
      <ref id="R53">
        <label>53</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levine</surname><given-names>M. E.</given-names></name></person-group>, 
<article-title>Modeling the rate of senescence: Can estimated biological age predict mortality more accurately than chronological age?</article-title>
<source>J. Gerontol. A Biol. Sci. Med. Sci.</source>
<volume>68</volume>, 
<fpage>667</fpage>â<lpage>674</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23213031</pub-id></mixed-citation>
      </ref>
      <ref id="R54">
        <label>54</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khoury</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>B. H.</given-names></name>, <name name-style="western"><surname>Diamond</surname><given-names>E. L.</given-names></name>, <name name-style="western"><surname>Chase</surname><given-names>G. A.</given-names></name>, <name name-style="western"><surname>McKusick</surname><given-names>V. A.</given-names></name></person-group>, 
<article-title>Inbreeding and prereproductive mortality in the Old Order Amish. III. Direct and indirect effects of inbreeding</article-title>. <source>Am. J. Epidemiol.</source>
<volume>125</volume>, 
<fpage>473</fpage>â<lpage>483</lpage> (<year>1987</year>).<pub-id pub-id-type="pmid">3812453</pub-id></mixed-citation>
      </ref>
      <ref id="R55">
        <label>55</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cawthon</surname><given-names>R. M.</given-names></name></person-group>, 
<article-title>Telomere measurement by quantitative PCR</article-title>. <source>Nucleic Acids Res.</source>
<volume>30</volume>, 
<fpage>e47</fpage> (<year>2002</year>).<pub-id pub-id-type="pmid">12000852</pub-id></mixed-citation>
      </ref>
      <ref id="R56">
        <label>56</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pooley</surname><given-names>K. A.</given-names></name>, <name name-style="western"><surname>Sandhu</surname><given-names>M. S.</given-names></name>, <name name-style="western"><surname>Tyrer</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Driver</surname><given-names>K. E.</given-names></name>, <name name-style="western"><surname>Luben</surname><given-names>R. N.</given-names></name>, <name name-style="western"><surname>Bingham</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Ponder</surname><given-names>B. A. J.</given-names></name>, <name name-style="western"><surname>Pharoah</surname><given-names>P. D. P.</given-names></name>, <name name-style="western"><surname>Khaw</surname><given-names>K.-T.</given-names></name>, <name name-style="western"><surname>Easton</surname><given-names>D. F.</given-names></name>, <name name-style="western"><surname>Dunning</surname><given-names>A. M.</given-names></name></person-group>, 
<article-title>Telomere length in prospective and retrospective cancer case-control studies</article-title>. <source>Cancer Res.</source>
<volume>70</volume>, 
<fpage>3170</fpage>â<lpage>3176</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20395204</pub-id></mixed-citation>
      </ref>
      <ref id="R57">
        <label>57</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimura</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Stone</surname><given-names>R. C.</given-names></name>, <name name-style="western"><surname>Hunt</surname><given-names>S. C.</given-names></name>, <name name-style="western"><surname>Skurnick</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Harley</surname><given-names>C. B.</given-names></name>, <name name-style="western"><surname>Aviv</surname><given-names>A.</given-names></name></person-group>, 
<article-title>Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths</article-title>. <source>Nat. Protoc.</source>
<volume>5</volume>, 
<fpage>1596</fpage>â<lpage>1607</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">21085125</pub-id></mixed-citation>
      </ref>
      <ref id="R58">
        <label>58</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>R. M.</given-names></name>, <name name-style="western"><surname>Bierig</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Devereux</surname><given-names>R. B.</given-names></name>, <name name-style="western"><surname>Flachskampf</surname><given-names>F. A.</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Pellikka</surname><given-names>P. A.</given-names></name>, <name name-style="western"><surname>Picard</surname><given-names>M. H.</given-names></name>, <name name-style="western"><surname>Roman</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Seward</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Shanewise</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Solomon</surname><given-names>S. D.</given-names></name>, <name name-style="western"><surname>Spencer</surname><given-names>K. T.</given-names></name>, <name name-style="western"><surname>St John Sutton</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>W. J.</given-names></name></person-group>, 
<article-title>Recommendations for chamber quantification: A report from the American Society of Echocardiographyâs Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology</article-title>. <source>J. Am. Soc. Echocardiogr.</source>
<volume>18</volume>, 
<fpage>1440</fpage>â<lpage>1463</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">16376782</pub-id></mixed-citation>
      </ref>
      <ref id="R59">
        <label>59</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stein</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Korcarz</surname><given-names>C. E.</given-names></name>, <name name-style="western"><surname>Hurst</surname><given-names>R. T.</given-names></name>, <name name-style="western"><surname>Lonn</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Kendall</surname><given-names>C. B.</given-names></name>, <name name-style="western"><surname>Mohler</surname><given-names>E. R.</given-names></name>, <name name-style="western"><surname>Najjar</surname><given-names>S. S.</given-names></name>, <name name-style="western"><surname>Rembold</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Post</surname><given-names>W. S.</given-names></name></person-group>, 
<article-title>Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: A consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force <italic>Endorsed by the Society for Vascular Medicine</italic></article-title>. <source>J. Am. Soc. Echocardiogr.</source>
<volume>21</volume>, 
<fpage>93</fpage>â<lpage>111</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18261694</pub-id></mixed-citation>
      </ref>
      <ref id="R60">
        <label>60</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>B. D.</given-names></name>, <name name-style="western"><surname>Hsueh</surname><given-names>W.-C.</given-names></name>, <name name-style="western"><surname>King</surname><given-names>T. M.</given-names></name>, <name name-style="western"><surname>Pollin</surname><given-names>T. I.</given-names></name>, <name name-style="western"><surname>Sorkin</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Agarwala</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>SchÃ¤ffer</surname><given-names>A. A.</given-names></name>, <name name-style="western"><surname>Shuldiner</surname><given-names>A. R.</given-names></name></person-group>, 
<article-title>Heritability of life span in the Old Order Amish</article-title>. <source>Am. J. Med. Genet.</source>
<volume>102</volume>, 
<fpage>346</fpage>â<lpage>352</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11503162</pub-id></mixed-citation>
      </ref>
      <ref id="R61">
        <label>61</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Friedman</surname><given-names>G. D.</given-names></name>, <name name-style="western"><surname>Cutter</surname><given-names>G. R.</given-names></name>, <name name-style="western"><surname>Donahue</surname><given-names>R. P.</given-names></name>, <name name-style="western"><surname>Hughes</surname><given-names>G. H.</given-names></name>, <name name-style="western"><surname>Hulley</surname><given-names>S. B.</given-names></name>, <name name-style="western"><surname>Jacobs</surname><given-names>D. R.</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Liu</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Savage</surname><given-names>P. J.</given-names></name></person-group>, 
<article-title>CARDIA: Study design, recruitment, and some characteristics of the examined subjects</article-title>. <source>J. Clin. Epidemiol.</source>
<volume>41</volume>, 
<fpage>1105</fpage>â<lpage>1116</lpage> (<year>1988</year>).<pub-id pub-id-type="pmid">3204420</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>